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Nephrotoxicity is the main side effect of antibiotics such as gentamicin. Preconditioning has been reported to protect against
injuries as ischemia/reperfusion. The objective of the present study was to determine the effect of preconditioning with
gentamicin on LLC-PK1 cells. Preconditioning was induced in LLC-PK1 cells by 24-h exposure to 2.0 mM gentamicin (G/IU).
After 4 or 15 days of preconditioning, cells were again exposed to gentamicin (2.0 mM) and compared to untreated control or G/
IU cells. Necrosis and apoptosis were assessed by acridine orange and HOESCHT 33346. Nitric oxide (NO) and endothelin-1
were assessed by the Griess method and available kit. Heat shock proteins were analyzed by Western blotting. After 15 days
of preconditioning, LLC-PK1 cells exhibited a significant decrease in necrosis (23.5 ± 4.3 to 6.5 ± 0.3%) and apoptosis (23.5 ±
4.3 to 6.5 ± 2.1%) and an increase in cell proliferation compared to G/IU. NO (0.177 ± 0.05 to 0.368 ± 0.073 μg/mg protein) and
endothelin-1 (1.88 ± 0.47 to 2.75 ± 0.53 pg/mL) production significantly increased after 15 days of preconditioning compared to
G/IU. No difference in inducible HSP 70, constitutive HSC 70 or HSP 90 synthesis in tubular cells was observed after
preconditioning with gentamicin. The present data suggest that preconditioning with gentamicin has protective effects on
proximal tubular cells, that involved NO synthesis but not reduction of endothelin-1 or production of HSP 70, HSC 70, or HSP 90.
We conclude that preconditioning could be a useful tool to prevent the nephrotoxicity induced by gentamicin.
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Introduction
Exposure of an organ, tissue, or cells to a mild stress
protects them against the effects of a subsequent equal or
more severe stress (1,2). This preconditioning phenome-
non has been observed in various organs such as the brain
(3), skeletal muscle (4), liver (5), intestine (6), lung (7), and
kidney (8). It has also been reported in different kinds of
injury such as ischemia (8) and heat shock (9). For ex-
ample, the functional parameters of rat kidneys were im-
proved by preconditioning with two successive cycles of
ischemia/reperfusion (10). Pretreatment with vitamin D3
resulted in a protective effect against subsequent ische-
mia/reperfusion injury of the rat (11). Preconditioning can
also induce crossover protection from another injury. For
example, prior exposure of cultured neuronal cells to el-
evated temperature protects them against subsequent
treatment with glutamate (9,12).
The mechanisms involved in preconditioning are not
fully understood, but may depend on the release of endog-
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enous protective mediators such as adenosine (13), pros-
tacyclin (14), bradykinin (15), nitric oxide (NO) (9), opening
of KATP channels (16), endothelin 1 decrease (17), and
heat shock protein (HSP) synthesis (18). The protective
effect of the initial preconditioning stress may involve the
ability of tissue to induce HSP synthesis (19,20) and to
increase NO production (21).
Gentamicin is an aminoglycoside antibiotic widely used
for the treatment of Gram-negative infections and is a well-
known cause of renal failure, which occurs in 10-20% of
patients receiving this drug (22). Gentamicin-induced neph-
rotoxicity is characterized by tubular necrosis mainly in-
volving proximal tubules (23).
It has been shown that oxidative stress is involved in
gentamicin-induced renal damage (24). There is also a
marked decrease in glomerular filtration rate, ultrafiltration
coefficient and glomerular plasma flow (25). Gentamicin-
induced nephrotoxicity has been only prevented in clinical
practice by the use of antioxidants such as n-acetylcys-
teine (26). Specific and effective strategies are necessary
to treat or prevent nephrotoxicity induced by gentamicin.
The objective of the present study was to determine the
effect of preconditioning with gentamicin on proximal tubu-
lar epithelial cells (LLC-PK1) by measuring necrosis, ap-
optosis and proliferation rates, endothelin-1, NO synthe-
sis, and HSP expression.
Material and Methods
Cell culture
LLC-PK1, derived from the renal epithelial cells of
Hampshire pigs and presenting the proximal tubule phe-
notype, were purchased from the American Type Culture
Collection and grown in Dulbecco’s modified Eagle’s me-
dium (DMEM, Sigma, USA) supplemented with 5% fetal
bovine serum (FBS, Gibco, USA), 24 mM NaHCO3, 10 mM
N’-2-hydroxyethylpiperazine-N’-2-ethanesulfonic acid, and
10,000 U/L penicillin/streptomycin. Cells were grown to
semiconfluence at 37°C in a humidified atmosphere con-
taining 5% carbon dioxide, and then, 0.5% (w/v) trypsin
(Cultilab, Brazil) was used to detach the cells from the
plastic flasks. The cells were subsequently centrifuged,
resuspended in DMEM, and subcultured in 25-cm2 plastic
culture flasks or 6-well plates for the experimental proce-
dures.
Experimental groups
After semiconfluence was reached, the medium was
replaced with FBS-free DMEM and the 1 x 106 cells were
assigned to the following treatment groups: control (CTL),
cells exposed to FBS-free DMEM for 24 h; G/IU, cells
treated with 2 mM gentamicin for 24 h; G/ID-4d, cells
previously exposed to 2.0 mM gentamicin for 24 h and
treated again with 2.0 mM gentamicin for 24 h, 4 days after
the first insult; G/ID-15d, cells previously exposed to gen-
tamicin for 24 h and treated again with gentamicin for 24 h
15 days after the first insult. At least 6 experimental situa-
tions in each group were analyzed.
Cell viability
Cell viability was determined by the exclusion of the
fluorescent dyes acridine orange and ethidium bromide
(Sigma) (27). Cells were trypsinized and 10 μL of the cell
suspensions was incubated with 0.3 μL acridine orange/
ethidium bromide solution (100 μg/mL). Ethidium bromide
is cell permeable and binds to either double-stranded DNA
emitting a green fluorescence (excitation 502 nm and
emission 525 nm), or to the single-stranded RNA emitting
a reddish-orange fluorescence (excitation 460 nm and
emission 650 nm). In contrast, acridine orange binds only
to double-stranded DNA and emits a red fluorescence
(excitation 510 nm and emission 595 nm); however, the
cell is not permeable to the dye when the plasma mem-
brane is intact, and therefore only necrotic cells will take up
this dye (with the red fluorescence quashing the green/
orange of acridine orange). Cell suspensions were ob-
served under a fluorescent microscope at 40X magnifica-
tion, and 200 cells per culture flasks were counted. Cells
emitting green fluorescence were considered viable, and
those emitting red fluorescence were considered nonvi-
able (necrotic). Viable cells are reported as a percentage
of the total cells counted.
Apoptosis
Apoptotic cells were determined using the HOE 33342
[Bisbenzimide HOE 33342 (2’-[4-ethoxyphenyl]-5-[4-meth-
yl-1-piperazinyl]-2,5’-bi-1H-benzimidazole) trihydrochloride]
dye. LLC-PK1 suspensions were centrifuged, resuspended
in PBS and incubated with 10 μL HOE 33342 (1.0 mM)
solution for 5-15 min for chromatin staining (28).
Cells were observed under the light microscope. Blue
cells were considered to be non-apoptotic, and cells with
condensed chromatin were considered to be apoptotic. At
least 100 cells per culture flask were counted, and the
results are reported as percentage of necrotic or apoptotic
cells.
Proliferation
Cell proliferation was determined by cell counting. LLC-
PK1 control cells (1 x 104 cell) were seeded onto 24-well
plates and treated with DMEM + 0.5% FBS. LLC-PK1 cells
previously exposed to gentamicin for 15 days (G/ID-15d)
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or cells without any treatment (G/IU) were seeded onto 24-
well plates and treated with DMEM + 0.5% FBS and 2.0
mM gentamicin. Cells were counted in a Neubauer cham-
ber with Trypan blue at 12-h intervals for 6 days and the
results are reported as mean ± SE number of viable cells.
Endothelin-1 synthesis
The concentration of endothelin-1 in cell suspensions
was measured with a commercial ELISA kit (IBL Co.,
Japan).
The concentrations of endothelin-1 were assessed in
culture medium of LLC-PK1 cells preconditioned with gen-
tamicin (G/ID) or not (CTL and G/IU). All assays were
performed in triplicate according to manufacturer proto-
cols. The absorbance (450 nm) of each sample was read
by the Ultra Microplate Reader EL808 (Bio-Tek Instru-
ments, USA) and is reported as pg/mL. The sensitivity of
the method was 0.78 ~100 pg/mL. The inter–assay varia-
tion was 4.96 ± 0.40, CV = 8.1%, and the intra–assay
variation was 4.76 ± 0.40, CV = 8.5%
Nitric oxide determination
NO in the cell culture media was determined by Griess
(29). Briefly, a solution of 1% sulfanilamide in 5% H3PO4
containing 0.1% naphthylethylenediamine (Sigma) was
added to aliquots of media and absorbance at 546 nm was
measured using a GENESYS 2 spectrophotometer (Spec-
tronic Instruments, Inc., USA). Nitrite, one of the stable
metabolites of NO, was then estimated by comparison with
a standard curve constructed with NaNO2. The protein
content of the culture media was assessed by the method
of Lowry et al. (30) and the absorbance compared to an
albumin standard curve. NO quantification was reported in
μg/mg of protein in each experimental situation.
Western blotting
Cells were lysed with 600 μL lysis buffer (50 mM Tris,
pH 8.0, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium
deoxycholate, 0.1% SDS, 2.5 mM EDTA, 1 mM PMSF, and
44 mM o-phenanthrolene) per plate (100/20 mm). The
lysates were centrifuged at 12,000 g for 5 min at 4°C and
the supernatants were stored at -80°C. Protein concentra-
tion was determined with the reagents from BioRad (USA)
by the Bradford method, using a calibration curve contain-
ing bovine serum albumin. Lysate containing 30 μg protein
was separated by 7.5-10% sodium dodecyl sulfate poly-
acrylamide gel electrophoresis and electrophoretically
transferred to nitrocellulose membranes using a Trans-
Blot SD Semi-Dry Electrophoretic Transfer Cell (BioRad).
Nonspecific binding sites were blocked with 5% non-fat
dried milk (v/v) in TBS buffer containing 10 mM Tris-HCl,
pH 7.5, and 200 mM NaCl. Immunoblots were incubated
overnight at 4°C with the following primary antibodies:
1:1000 HSP 70, 1:1000 HSP 90, 1:1000 constitutive HSP
(HSC) 70 (Stressgen, Assay Designs, USA), and 1:2000
inducible NO synthase (iNOS, Santa Cruz, USA). After
washing three times with TBS-T (Tris-HCl, pH 7.5, 200 mM
NaCl, 0.05% Tween-20), membranes were incubated for 1
h at 4°C in alkaline phosphatase-conjugated secondary
antibodies (1:1000; Stressgen, Assay Designs) and then
washed three times with TBS-T. Immunoreactive protein
bands were visualized using the NBT/BCIP detecting re-
agents (Molecular Probes, Invitrogen, USA). Nitrocellu-
lose membranes were scanned digitally and analyzed
using an Imaging Densitometer (Model GS670, USA) and
the Quantity One-GS710 software (USA).
Statistical analysis
Data are reported as means ± SEM. The experimental
and control groups were compared by one-way analysis of
variance (ANOVA) followed by the Dunn or Tukey test for
multiple comparisons, with the level of significance set at
5% (P < 0.05).
Results
Figure 1A shows the necrotic death of LLC-PK1 cells
preconditioned or not with gentamicin. Necrotic cell death
after treatment with gentamicin increased significantly com-
pared to control (G/IU: 23.5 ± 4.3 vs CTL: 11.8 ± 4.5%; P <
0.05, respectively). After 4 days of preconditioning, there
was no difference in the necrosis rate induced by gentami-
cin (G/ID-4d: 23.9 ± 8.3%) compared to G/IU, but after 15
days of preconditioning, the necrosis rate induced by
gentamicin decreased significantly (G/ID-15d: 6.56 ± 0.3%)
compared to G/IU.
Figure 1B shows the apoptotic rate of LLC-PK1 cells
preconditioned with gentamicin. There was a significant
increase in apoptotic cells after treatment with gentamicin
compared to control (G/IU: 26.5 ± 2.8 vs CTL: 3.2 ± 1.2%).
After 4 days (G/ID-4d) of preconditioning, there was a
significant decrease in the apoptotic rate from 26.5 ± 2.8 to
4.6 ± 1.5%, which persisted after 15 days of precondition-
ing (G/ID-15d: 6.5 ± 2.1%).
Figure 1C shows the proliferation pattern of LLC-PK1
cells preconditioned with gentamicin in the same experi-
mental situations. There was a decrease in cell prolifera-
tion after treatment with gentamicin (G/IU) compared to
control. After preconditioning with gentamicin for 15 days
(G/ID-15d), proliferation was increased compared to con-
trol even in the presence of gentamicin.
In an attempt to identify mechanisms of protection
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Figure 1. Effect of preconditioning with gentamicin
on gentamicin-induced (A) necrotic cell death, (B)
apoptotic cell death and (C) proliferation in LLC-
PK1 cells. Control cells grown in culture (CTL) were
exposed to gentamicin (2.0 mM; G/IU) or cells pre-
viously exposed to gentamicin were reexposed af-
ter 4 days (G/ID-4d) or 15 days (G/ID-15d). Data
are reported as mean ± SEM. *P < 0.05 compared
to CTL; +P < 0.05 compared G/IU (one-way ANOVA
followed by the Dunn or Tukey test for multiple
comparisons).
induced by preconditioning with gentamicin in LLC-PK1
cells, we determined NO production in the culture medium
of LLC-PK1 cells preconditioned with gentamicin (Figure
2A). There was no difference in NO production between
tubular cells exposed to gentamicin and control (G/IU:
0.172 ± 0.014 vs CTL: 0.177 ± 0.05 μM/mg protein).
Nevertheless, in tubular cells preconditioned with gen-
tamicin there was a significant increase in NO production
after 15 days (G/ID-15d: 0.368 ± 0.073 μM/mg protein).
In Figure 2B, we report the viability of LLC-PK1 cells
preconditioned with gentamicin for 15 days in the presence
or not of 5 mM L-NAME. There was a significant increase in
apoptotic and necrotic cell death after treatment with gen-
tamicin. After 15 days of preconditioning, the necrotic and
apoptotic rate returned to control levels. However, in the
presence of L-NAME, there was a significant increase in
necrosis (G/ID-15d: 6.6 ± 1.1 vs G/ID-15d + L-NAME: 81.6 ±
1.9%) and apoptosis (G/ID-15d: 12.3 ± 1.6 vs G/ID-15d + L-
NAME: 85.3 ± 1.7%) of cells preconditioned for 15 days. The
treatment of LLC-PK1 cells with gentamicin induced the
expression of iNOS, which persisted for at least 15 days after
preconditioning with gentamicin (Figure 2C).
Figure 2D shows endothelin-1 synthesis in LLC-PK1
cells preconditioned with gentamicin. There was a signifi-
cant increase in endothelin-1 production when tubular
cells were exposed to gentamicin compared to control (G/
IU: 1.88 ± 0.47; CTL: 0.40 ± 0.22 pg/mL), which persisted
after 15 days of preconditioning (G/ID-15d: 2.76 ± 0.52 pg/
mL).
Under the conditions employed in the present study,
preconditioning of LLC-PK1 cells with gentamicin did not
induce HSP 70 (G-ID/15d: 2.8 ± 0.9; G-IU: 2.8 ± 0.8; CTL:
2.9 ± 0.6 pixels ratio between HSP 70/β-actin), HSC 70 (G-
ID/15d: 1.9 ± 0.4; G-IU: 2.1 ± 0.3; CTL: 2.4 ± 0.5 pixels ratio
between HSC 70/β-actin), or HSP 90 (G-ID/15d: 1.1 ± 0.3;
G-IU: 1.0 ± 0.3; CTL: 0.9 ± 0.2 pixels ratio between HSP
90/β-actin) production compared to G/IU or control condi-
tion.
Discussion
The protective mechanisms induced by precondition-
ing with gentamicin in the kidney are unknown. The aim of
the present study was to evaluate the consequences of
preconditioning with gentamicin in proximal tubular cells.
The nephrotoxicity induced by gentamicin is characterized
by tubular cell damage (31) and a reduction of renal blood
flow and glomerular filtration rate (25).
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A significant decrease in gentamicin-induced apopto-
sis was observed after 4 days of preconditioning in tubular
cells, but the decrease in necrosis only occurred after 15
days. Preconditioning with gentamicin for 15 days increased
the proliferation of LLC-PK1 cells even in the presence of
the drug. In rat mesangial cells, incubation with gentamicin
induced apoptosis and proliferation (22).
The involvement of renal NO production in precondi-
tioning induced by ischemia/reperfusion has been previ-
ously proposed (32). Also, an increase in glomerular NO
production has been reported in rats with gentamicin-
induced renal failure (33).
The present study shows that NO production is in-
volved in preconditioning induced by gentamicin in LLC-
PK1 cells because preconditioning with gentamicin for 15
days resulted in a significant increase in NO production
and in iNOS expression in proximal tubular cells compared
to control. To our knowledge, this is the first time one study
shows that inhibition of constitutive and induced NO syn-
thase with L-NAME significantly increased necrotic and
apoptotic cell death in preconditioned LLC-PK1 cells, show-
ing that protection of preconditioning with gentamicin is
dependent on NO production.
Endothelin-1 stimulates hypertrophy, proliferation, and
extracellular matrix accumulation in the kidney, primarily
via endothelin type A (ETA) receptor stimulation. Selective
ETA receptor antagonists as well as combined ETA/ETB
receptor antagonists prevent the development of hyper-
tension, renal vasoconstriction, proteinuria, increased re-
nal matrix protein expression, and renal structural injury in
diabetic rats (34). A decrease in endothelin-1 overproduc-
tion was observed in ischemia/reperfusion preconditioning
in rats (35,36). However, a decrease of endothelin-1 was
not observed in the preconditioning induced by gentamicin
in proximal tubular cells in the present protocol. We did not
observe inhibition of gentamicin-induced endothelin-1 over-
production after preconditioning for 15 days. It is possible
that the increase in endothelin-1 in LLC-PK1 cells after
preconditioning with gentamicin is related to the prolifera-
tion observed in our experimental model.
Some studies have reported the participation of HSP in
several preconditioning models. The increase in HSP 70 is
directly proportional to the degree of protection induced by
ischemic or heat preconditioning in neuronal cells (37). In
Figure 2. Effect of preconditioning with gentamicin on (A) nitric oxide production, (B) necrotic cell death, (C) endothelin-1 production,
and (D) iNOS expression by Western blotting. Control cells were grown in culture (CTL), exposed to gentamicin (2.0 mM; G/IU) or
reexposed after 15 days (G/ID-15d) to gentamicin with or without L-NAME (5 mM) (G/ID-15d + L-NAME). *P < 0.05 compared to CTL;
#P < 0.05 compared to G/IU; +P < 0.05 compared to G/ID-15d (one-way ANOVA followed by the Dunn or Tukey test for multiple
comparisons).
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contrast, overexpression of HSP 70 in the kidney after
ischemic or thermal preconditioning does not correlate
with protection from hypoxic injury (38). Our results agree
with these findings since we did not observe any increase
in inducible HSP 70, constitutive HSC 70 or HSP 90 in the
present experimental situation.
Our results showed that NO is involved in precondition-
ing induced by gentamicin of kidney tubular cells. Treat-
ment with NO donors could be a useful tool to treat or
prevent this nephrotoxicity.
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